Citeline Podcasts

In this edition of Device Week, Medtech Insight's deputy editor Reed Miller chats with managing editor Marion Webb about her latest in-depth Market Intel story, the first part of a two-part series on the competitive landscape of the global insulin pump market.

Listen to the podcast via the player below:

Market Intel: After A Year Of Partnerships, Insulin Pump Manufacturers Will Face Fierce Competition In 2020

https://medtech.pharmaintelligence.informa.com/MT125985/Market-Intel-After-A-Year-Of-Partnerships-Insulin-Pump-Manufacturers-Will-Face-Fierce-Competition-In

For more information on Medtech Insight and to start a free trial, click here:

http://bit.ly/2w7LnlR

Over the past year a number of medical device sterilization facilities that use ethylene oxide, or EtO, have shut down as US state regulators have raised concerns about their potential environmental impact. On this week’s podcast, executive editor Shawn M. Schmitt chats with senior reporter Danny Al-Faruque about what’s happened to date, as well as where this EtO issue is headed in the future.

Medtech Insight articles addressing topics discussed in this episode:

• Risk Of Sterilization Plant Shutdowns Across US Sends Shockwave Through Industry

https://medtech.pharmaintelligence.informa.com/MT125844/Risk-Of-Sterilization-Plant-Shutdowns-Across-US-Sends-Shockwave-Through-Industry

• US FDA Experts Caution Against Banning EtO, Encourage More Duodenoscope Training

https://medtech.pharmaintelligence.informa.com/MT125882/US-FDA-Experts-Caution-Against-Banning-EtO-Encourage-More-Duodenoscope-Training

• Listen: Medtronic Exec Highlights Ethylene Oxide Standards At First Day Of FDA EtO Meeting

https://medtech.pharmaintelligence.informa.com/MT125874/Listen-Medtronic-Exec-Highlights-Ethylene-Oxide-Standards-At-First-Day-Of-FDA-EtO-Meeting

• Teleflex Says It Will Lose $9m – And Maybe More – Due To EtO Plant Shutdown

https://medtech.pharmaintelligence.informa.com/MT125869/Teleflex-Says-It-Will-Lose-$9m--And-Maybe-More--Due-To-EtO-Plant-Shutdown

Hosted by the Scrip Pharma Intelligence team in London. Looking at Novartis’ acquisition of The Medicines Company; are there secret UK-US trade talks on medicines; Highlights from the Jefferies Healthcare investor conference.

In this edition of Device Week, Medtech Insight’s Catherine Longworth chats to Reed Miller about the big clinical trial news from the American Heart Association meeting held in Philadelphia and provides an investor update from the Jefferies Healthcare Conference in London.

For more information on Medtech Insight and to start a free trial, click here: http://bit.y/2w7LnlR

Enforcement of the False Claims Act is always a hot-button topic for industry. That’s because fines for FCA violations can be costly, reaching into the billions of dollars. On this week’s podcast, executive editor Shawn M. Schmitt chats with senior reporter Elizabeth Orr about some of the more important FCA cases from 2019.

Medtech Insight articles addressing topics discussed in this episode:

• FCA 2019: Key Issues Include DOJ Dismissal, Statute Of Limitations

• Neurosurgeon, PODs Subject Of DOJ Spinal Device Probe

Pink Sheet reporters discuss the key takeaways from Stephen Hahn's confirmation hearing to become FDA commissioner, as well as a few items from the Fall 2019 regulatory agenda.

Pink Sheet reporters preview the Stephen Hahn confirmation hearing for the FDA commissioner role, and also look at the revocation of buprenorphine's orphan drug designation and Rick Pazdur's comments on Project Orbis.

In this edition of Device Week, Medtech Insight managing editor Marion Webb summarizes her interviews with Ted Tanner, the CTO of IBM Watson Health, and Catherine Mohr, president of the Intuitive Foundation. Both executives addressed the Exponential Medicine conference in San Diego about the future of global medtech. Deputy Editor Reed Miller discusses the appointment of Robert Ford as the new CEO of Abbott Laboratories, the latest in a recent series of high-profile CEO appointments in medtech.

Medtech Insight articles addressing topics discussed in this episode:

Exec Chat: XMed2019: How IBM Watson Health's CTO Uses Blockchain To Eliminate 'Friction Points' In Health Care

http://bit.ly/2qdmnJv

Exec Chat: XMed 2019: Intuitive Foundation's President Catherine Mohr's Team Jackets Read 'Plan For 100 Years'

http://bit.ly/2qR4aBq

Medtech Veteran Robert Ford Will Take Over As Abbott CEO From Miles White

http://bit.ly/2qcCZks

Medtronic CEO Omar Ishrak Announces Retirement; Geoff Martha Will Be New CEO

http://bit.ly/2CLuXBM

BD Names COO Thomas Polen As Next CEO; Vince Forlenza Will Retire In January

http://bit.ly/32NyPwX

FDA's Suzanne Schwartz discusses her take on a recent advisory committee meeting to discuss ethylene oxide sterilization and duodenoscope infections.

Device Week, 8 November 2019 – Medicare Rules!

Some exciting changes to US Medicare payment rules will take effect in January for device-related procedures performed in different hospital settings. On this week’s podcast, executive editor Shawn M. Schmitt chats with senior reporter Sue Darcey, who covered these changes for Medtech Insight – as well news out of the Centers for Medicare and Medicaid Services (CMS) that it designated several new medical technologies for passthrough payments and will offer new home-use infusion therapy benefits.

Medtech Insight articles addressing topics discussed in this episode:

• Final 2020 CMS Outpatient, ASC Payment Rules Broaden Patient Access To Medtech (https://medtech.pharmaintelligence.informa.com/MT125873/Final-2020-CMS-Outpatient-ASC-Payment-Rules-Broaden-Patient-Access-To-Medtech)

• CMS Releases Final 2020 Home-Health Rule On Payments For Home Infusion-Therapy Equipment (https://medtech.pharmaintelligence.informa.com/MT125866/CMS-Releases-Final-2020-HomeHealth-Rule-On-Payments-For-Home-InfusionTherapy-Equipment)